Trials / Conditions / Vascular Ehlers-Danlos Syndrome

Vascular Ehlers-Danlos Syndrome

10 registered clinical trials studyying Vascular Ehlers-Danlos Syndrome — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Metabolic Phenotyping in vEDS NCT07516496	Cambridge University Hospitals NHS Foundation Trust	—
Suspended	Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Pat NCT05463679	Aytu BioPharma, Inc.	Phase 3
Recruiting	Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients NCT05994664	Baylor College of Medicine	N/A
Completed	Single-Session "Empowered Relief" Class for Marfan Syndrome and Related Conditions NCT05980104	Stanford University	N/A
Recruiting	Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndro NCT05432466	Acer Therapeutics Inc.	Phase 3
Unknown	Characterization of Bleeding Disorders in EDS NCT05434728	University Health Network, Toronto	—
Active Not Recruiting	Pathogenetic Basis of Aortopathy and Aortic Valve Disease NCT03440697	Yale University	—
Completed	Biomarkers in Vascular Ehlers-Danlos Syndrome NCT02165085	Assistance Publique - Hôpitaux de Paris	—
Completed	Non-Invasive Quantitative Imaging of Human Local Arterial Wall Elasticity Using Supersonic Shear Imaging NCT01096264	French Cardiology Society	N/A